Longitudinal extensive transverse myelitis—it's not all neuromyelitis optica (Q37951805)

25 August 2017

title

Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica (English)

1 reference

25 August 2017

Longitudinal extensive transverse myelitis—it's not all neuromyelitis optica (English)

1 reference

DOI

https://api.crossref.org/works/10.1038/NRNEUROL.2011.176

16 December 2024

4

Paulus Rommer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22045269

16 December 2024

author name string

Corinna Trebst

1

1 reference

25 August 2017

Peter Raab

2

1 reference

25 August 2017

Elke Verena Voss

3

1 reference

25 August 2017

Mazen Abu-Mugheisib

5

1 reference

25 August 2017

Martin Stangel

7

1 reference

25 August 2017

Uwe K. Zettl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22045269

16 December 2024

language of work or name

English

0 references

publication date

1 November 2011

1 reference

full work available at URL

25 August 2017

http://www.nature.com/articles/nrneurol.2011.176.pdf

1 reference

https://api.crossref.org/works/10.1038/NRNEUROL.2011.176

http://www.nature.com/articles/nrneurol.2011.176

16 December 2024

1 reference

DOI

https://api.crossref.org/works/10.1038/NRNEUROL.2011.176

16 December 2024

published in

Nature Reviews Neurology

1 reference

25 August 2017

volume

7

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

688-698

1 reference

Proposed diagnostic criteria and nosology of acute transverse myelitis

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

An approach to the diagnosis of acute transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Clinical practice. Transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Differential diagnosis of T2 hyperintense spinal cord lesions: Part A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Differential diagnosis of T2 hyperintense spinal cord lesions: part B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Magnetic resonance imaging of intramedullary spinal cord lesions: a pictorial review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Diagnosis and treatment of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

NMO-IgG predicts the outcome of recurrent optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Longitudinal myelitis in a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Sarcoidosis and its neurological manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Behçet's disease: recent advances in early diagnosis and effective treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Subacute longitudinal myelitis associated with Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Longitudinally extensive myelopathy in Caucasians: a West Australian study of 26 cases from the Perth Demyelinating Diseases Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Acute Disseminated Encephalomyelitis: Current Understanding and Controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

21 January 2018

Infectious myelopathies

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Acute transverse myelitis as a main manifestation of early stage II neuroborreliosis in two patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Subacute syphilitic meningomyelitis with characteristic spinal MRI findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Nonenhancing intramedullary astrocytomas and other MR imaging features: a retrospective study and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Inflammatory transverse myelitis: evolving concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Amphiphysin autoimmunity: paraneoplastic accompaniments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Spinal vascular malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Value and limitations of contrast-enhanced MR angiography in spinal arteriovenous malformations and dural arteriovenous fistulas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Copper deficiency myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

The rescue effect of plasma exchange for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

EFNS guidelines on diagnosis and management of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Diagnostik und Therapie der Neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Neurosarcoidosis: Diagnosis and Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Dramatic response to infliximab in refractory neurosarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Effect of infliximab in progressive neuro-Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Tuberculosis of the central nervous system: overview of neuroradiological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Neuropsychiatric systemic lupus erythematosus: Lessons learned from magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Clinical characteristics and course of spinal cord involvement in Behçet's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Syphilitic myelitis: rare, nonspecific, but treatable

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Clinically suspected fibrocartilaginous embolism: clinical characteristics, treatments, and outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

[Infliximab treatment for chronic sarcoidosis--a case series]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.176

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

31 March 2020

1 reference

12 December 2020

Spinal cord schistosomiasis: MR imaging appearance with surgical and pathologic correlation

1 reference

12 December 2020

Vitamin B12 deficiency neurological syndromes: a clinical, MRI and electrodiagnostic study

1 reference

12 December 2020

Copper deficiency myeloneuropathy resembling B12 deficiency: partial resolution of MR imaging findings with copper supplementation

1 reference

12 December 2020

Medical therapy for systemic lupus erythematosus.

1 reference

12 December 2020

Sarcoidosis: clinical update.

1 reference

12 December 2020

Identifiers

DOI

1 reference

25 August 2017

1 reference